Publications

Tran HD*, Shin MK*, Yeo XY, Jung S, Muhammad J, Lim SB, Kim J, Woo HG, Denman CR, Han RR, Kim M, Jeon D, Kim H, Kim YJ, Mun JY, Lee EJ, Park SM, Kuhn B, Arbuthnott GW, Jo J#. Human striatal-midbrain assembloid model of the alpha-synuclein propagation. Brain, August 14,  2025;awaf326. 

Park S, Shin MK, Jeong DS, Yeo XY, Kim YJ, Muhammad J, Kim M, Gu S, Lee JE, Park Y, Lim SB, Mun JY, Jung S, Lee DR#, Jo J#. Human pluripotent stem cell-derived skeletal muscle organoid model of aging-induced sarcopenia. J Cachexia Sarcopenia and Muscle, August 14, 2025;16:e70045.

Tran HD, Denman CR, Shin MK, Jeon D, Kuhn B, Jo J#. Establishment of TH-EGFP human embryonic stem cell line for specific labeling of dopaminergic neurons. Stem Cell Research, November 14, 2024. 

Ahmed T, Jo J, Park SM. Targeting glucose metabolism: A novel therapeutic approach for Parkinson's disease. Cells, November 12, 2024.

Denman CR, Tran HD, Shin MK, Ryu J, Kuhn B, Jo J#. Generation of a human embryonic stem cell reporter line, TMEM119-EGFP, for the visualization of in vitro differentiated human microglia. Stem Cell Research, November 22, 2023.

Denman CR, Park SM, Jo J#. Gut-Brain Axis: Gut Dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease. Frontiers in Neuroscience, October 30, 2023.

Choi BY, Yang EM, Jung HW, Shin MK, Jo J, Cha HY, Park HS, Kang HC, Ye YM. Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor. Allergy, March 16, 2023.

Shin MK, Bang JS, Lee JE, Tran HD, Park G, Lee DR#, Jo J#. Generation of skeletal muscle organoids from human pluripotent stem cells to model myogenesis and muscle regeneration. International Journal of Molecular Sciences,  2022; 23(9), 5108.

Jo J*, Yang L*, Tran HD, You WJ, Sun AX, Jung BC, Lee SJ, Saw TY, Yaw LP, Xie J, Lokman H, Ong WY, Lim GGY, Lim KL, Tan EK, Ng HH, Je HS. Lewy-body inclusions in human midbrain organoid carrying GBA and SYN mutations. Annals of Neurology, 2021;90(3):490-505.

Kwak TH, Kang JH, Hali S, Kim J, Kim KP, Park C, Lee JH, Ryu HK, Jo J, Je HS, Ng HH, Kwon J, Kim NH, Hong KH, Sun W, Chung CH, Rhyu IJ, Han DW. Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling. Stem Cells, 2020;1-14. 

Before September 2019

Jo J*, Xiao Y, Sun AX, Cukuroglu E, Tran HD, Göke J, Tan ZY, Saw TY, Tan CP, Lokman H, Lee Y, Kim D, Ko HS, Kim SO, Park JH, Cho NJ, Hyde TM, Kleinman JE, Shin JH, Weinberger DR, Tan EK, Je HS, Ng HH. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin–producing neurons. Cell Stem Cell, 2016; 19(2):248-57 (Previewed in Cell Stem Cell, 145-6).

Hong S*, Jo J*, Kim HJ, Lee JE, Shin DH, Lee SG, Baek A, SH Shim, Lee DR. RuvB-like protein 2 (Ruvbl2) has a role in directing the neuroectodermal differentiation of mouse embryonic stem cells. Stem Cells and Development, 2016; 25(18):1376-85.

Jo J*, Hwang S*, Kim HJ*, Hong S, Lee JE, Lee SG, Baek A, Han H, Lee JI, Lee I, Lee DR. An integrated systems biology approach identifies positive cofactor 4 as a factor that increases reprogramming efficiency. Nucleic Acids Research, 2016; 18; 44(3):1203-15.

Yang NJ, Seol DW, Jo J, Jang HM, Yoon SY, Lee WS, and Lee DR. Supplementation with cell-penetrating peptide-conjugated estrogen-related receptor β (CPP-ESRRB) improves the formation of the inner cell mass and the development of vitrified/warmed mouse embryos. Reproductive Sciences, 2016; 23(11):1509-17.

Jo J*, Hong S*, Choi WY, Lee DR. Cell-penetrating peptide (CPP)-conjugated proteins is an efficient tool for manipulation of human mesenchymal stromal cells. Scientific Reports, 2014; 14; 4:4378.

Yang NJ, Seol DW, Jo J, Jang HM, Yoon SY, and Lee DR. Effect of cell-penetrating peptide-conjugated estrogen related receptor β (CPP-ESRRB) on the development of mouse embryos cultured in vitro. CERM, 2014; 41(1):1-8.

Choi S, Jo J, Seol DW, Cha SK, Lee JE, and Lee DR. Regulation of pluripotency-related genes and differentiation in mouse embryonic stem cells by direct delivery of cell-penetrating peptide-conjugated CARM1 recombinant protein. Dev Reprod, 2013; 17(1):9-16.

Jo J*, Song H, Park SG, Lee SH, Ko JJ, Park JH, Jeong J, Cheon YP and Lee DR. Regulation of differentiation potential of human mesenchymal stem cells by intracytoplasmic delivery of coactivator-associated arginine methyltransferase 1 (CARM1) protein using cell-penetrating peptide (CPP). Stem Cells, 2012; 30: 1703-1713.

Go YE, Kim HJ, Jo J, Lee HJ, Do JT, Ko JJ, and Lee DR. Comparative analysis for in vitro differentiation potential of induced pluripotent stem cells, embryonic stem cells, and multipotent spermatogonial stem cells into germ-lineage cells. Dev Reprod, 2011; 15(1): 41-52.

Jo J*, Lee Y, Ko JJ, Oh MH, Cheon YP, and Lee DR. Up-regulation of pluripotency-related genes in human amniotic fluid-derived stem cells by ESRRB conjugated with cell-penetrating peptide. Dev Reprod, 2010; 14(4): 243-251.